Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Celestica (CLS) Financials

Celestica logo
$342.31 -16.24 (-4.53%)
Closing price 05/18/2026 03:59 PM Eastern
Extended Trading
$339.98 -2.33 (-0.68%)
As of 04:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Celestica

Annual Income Statements for Celestica

This table shows Celestica's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 134 277 211 24 111 121 104 180 244 428 833
Consolidated Net Income / (Loss)		 134 277 211 24 111 121 123 180 244 428 833
Net Income / (Loss) Continuing Operations		 134 277 211 24 111 121 123 180 244 428 833
Total Pre-Tax Income 		176 301 239 24 141 151 136 239 306 532 983
Total Operating Income		 182 297 239 44 197 189 168 289 338 599 1,041
Total Gross Profit		 391 430 419 99 385 438 487 650 754 1,034 1,494
Total Revenue		 5,670 6,159 6,211 99 5,986 5,785 5,635 7,250 7,961 9,646 12,391
Operating Revenue		 5,670 6,159 6,211 99 5,986 5,785 5,635 7,250 7,961 9,646 12,391
Total Cost of Revenue		 5,248 5,617 5,734 0.00 5,504 5,311 5,148 6,600 7,207 8,612 10,897
Operating Cost of Revenue		 5,248 5,617 5,734 - 5,504 5,311 5,148 6,600 7,207 8,612 10,897
Total Operating Expenses		 240 245 238 55 285 286 309 360 416 434 453
Selling, General & Admin Expense		 208 211 203 - 227 231 245 267 303 294 260
Research & Development Expense		 23 25 26 - 28 30 38 46 61 78 118
Amortization Expense		 9.20 9.40 8.90 - 30 26 - 40 40 44 46
Restructuring Charge		 - - - - - - - 6.70 12 19 30
Total Other Income / (Expense), net		 -6.30 4.30 0.00 -20 -56 -38 -32 -50 -32 -67 -58
Interest Expense		 - - - - - - 32 52 79 52 53
Other Income / (Expense), net		 -6.30 -10 - -20 -56 -38 - 1.50 47 -15 -4.90
Income Tax Expense		 42 25 28 - 30 30 23 59 62 104 151
Basic Earnings per Share		 $0.43 $0.98 $0.74 - - $0.47 $0.82 $1.46 $2.03 $3.62 $7.22
Weighted Average Basic Shares Outstanding		 155.80M 141.80M 143.10M 136.29M 128.79M 129.10M 126.70M 123.50M 120.10M 118.10M 115.30M
Diluted Earnings per Share		 $0.42 $0.96 $0.73 - - $0.47 $0.82 $1.46 $2.03 $3.61 $7.16
Weighted Average Diluted Shares Outstanding		 157.90M 143.90M 145.20M 136.29M 128.79M 129.10M 126.70M 123.60M 120.30M 118.70M 116.20M
Weighted Average Basic & Diluted Shares Outstanding		 - - 141.81M 136.29M 128.79M 129.05M 124.71M 121.64M 118.95M 115.96M 114.97M

Quarterly Income Statements for Celestica

This table shows Celestica's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 92 95 90 152 86 211 268 268 212
Consolidated Net Income / (Loss)		 92 95 90 152 86 211 268 268 212
Net Income / (Loss) Continuing Operations		 92 95 90 152 86 211 268 268 212
Total Pre-Tax Income 		105 114 124 190 114 257 311 301 256
Total Operating Income		 126 133 138 203 129 273 325 314 272
Total Gross Profit		 222 254 261 297 274 371 416 433 437
Total Revenue		 2,209 2,392 2,500 2,546 2,649 2,893 3,194 3,655 4,047
Operating Revenue		 2,209 2,392 2,500 2,546 2,649 2,893 3,194 3,655 4,047
Total Cost of Revenue		 1,987 2,138 2,239 2,249 2,375 2,522 2,778 3,222 3,610
Operating Cost of Revenue		 1,987 2,138 2,239 2,249 2,375 2,522 2,778 3,222 3,610
Total Operating Expenses		 96 121 123 95 145 99 91 119 165
Selling, General & Admin Expense		 65 79 92 58 113 39 38 70 117
Research & Development Expense		 17 19 19 23 18 34 36 30 41
Amortization Expense		 10 11 11 12 11 11 11 12 11
Restructuring Charge		 4.80 12 1.00 2.10 3.90 15 4.90 6.40 -4.40
Total Other Income / (Expense), net		 -21 -19 -14 -13 -15 -15 -14 -13 -16
Interest Expense		 14 15 11 12 14 14 13 13 16
Other Income / (Expense), net		 -6.60 -4.40 -2.80 -1.20 -1.40 -1.70 -1.30 -0.50 0.20
Income Tax Expense		 13 19 35 38 28 46 43 34 44
Basic Earnings per Share		 $0.77 $0.80 $0.76 $1.29 $0.74 $1.83 $2.33 $2.32 $1.85
Weighted Average Basic Shares Outstanding		 119M 118.80M 118.20M 118.10M 115.90M 115.10M 115M 115.30M 114.90M
Diluted Earnings per Share		 $0.77 $0.80 $0.75 $1.29 $0.74 $1.82 $2.31 $2.29 $1.83
Weighted Average Diluted Shares Outstanding		 119.30M 119.40M 118.90M 118.70M 116.90M 115.90M 115.90M 116.20M 115.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 115.96M 114.99M 115.03M 115.04M 114.97M 114.97M

Annual Cash Flow Statements for Celestica

This table details how cash moves in and out of Celestica's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 118 3.50 -4.90 27 146 12 5.30 -20 -4.10 53 172
Net Cash From Operating Activities		 187 88 124 -465 275 185 -135 211 326 474 660
Net Cash From Continuing Operating Activities		 187 88 124 -465 275 185 -135 211 326 474 660
Net Income / (Loss) Continuing Operations		 67 126 106 99 70 61 104 180 244 428 833
Consolidated Net Income / (Loss)		 67 126 106 99 70 61 104 180 244 428 833
Depreciation Expense		 68 76 77 89 135 125 126 116 131 152 176
Non-Cash Adjustments To Reconcile Net Income		 55 -157 -70 -863 198 -147 -954 47 9.40 -17 -173
Changes in Operating Assets and Liabilities, net		 71 100 79 210 -129 147 589 -132 -58 -89 -176
Net Cash From Investing Activities		 -60 -63 -102 -79 36 -51 -50 -109 -122 -213 -204
Net Cash From Continuing Investing Activities		 -60 -63 -102 -79 36 -51 -50 -109 -122 -213 -204
Purchase of Property, Plant & Equipment		 - - - -82 -81 -53 -52 -109 -125 -171 -201
Acquisitions		 - - - - - - - 0.00 0.00 -36 0.00
Sale of Property, Plant & Equipment		 66 65 103 3.70 117 1.80 2.60 0.10 2.70 2.90 0.00
Other Investing Activities, net		 - - - - - - - 0.00 0.00 -8.40 -2.50
Net Cash From Financing Activities		 -9.50 -21 -28 570 -165 -122 190 -122 -208 -209 -284
Net Cash From Continuing Financing Activities		 -9.50 -21 -28 570 -165 -122 190 -122 -208 -209 -284
Repayment of Debt		 - 0.00 0.00 -352 -213 -122 -395 -1,269 -910 -1,427 -518
Repurchase of Common Equity		 - - - - - - - -80 -36 -272 -153
Issuance of Debt		 16 129 53 922 48 0.00 585 1,235 891 1,548 500
Issuance of Common Equity		 - - - - - - - 0.20 0.30 3.90 0.30
Other Financing Activities, net		 - - - - - - - -8.40 -154 -62 -113
Cash Interest Paid		 - - - - - - - 53 69 53 54
Cash Income Taxes Paid		 28 - 31 45 21 28 39 65 78 106 175

Quarterly Cash Flow Statements for Celestica

This table details how cash moves in and out of Celestica's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -62 126 -36 25 -120 11 -7.90 290 -218
Net Cash From Operating Activities		 108 100 123 143 130 152 126 251 356
Net Cash From Continuing Operating Activities		 108 100 123 143 130 152 126 251 356
Net Income / (Loss) Continuing Operations		 92 95 90 152 86 211 268 268 212
Consolidated Net Income / (Loss)		 92 95 90 152 86 211 268 268 212
Depreciation Expense		 36 37 39 40 37 45 40 53 40
Non-Cash Adjustments To Reconcile Net Income		 -14 4.30 19 -26 51 -70 -90 -65 44
Changes in Operating Assets and Liabilities, net		 -5.00 -37 -25 -23 -45 -34 -92 -4.50 60
Net Cash From Investing Activities		 -40 -70 -51 -51 -37 -35 -37 -95 -218
Net Cash From Continuing Investing Activities		 -40 -70 -51 -51 -37 -35 -37 -95 -218
Purchase of Property, Plant & Equipment		 -40 -37 -46 -48 -37 -33 -37 -95 -230
Sale of Property, Plant & Equipment		 - - - - 0.00 - - - 11
Net Cash From Financing Activities		 -130 96 -107 -68 -214 -107 -97 134 -356
Net Cash From Continuing Financing Activities		 -130 96 -107 -68 -214 -107 -97 134 -356
Repayment of Debt		 -262 -821 -25 -319 -165 -254 -94 -4.40 -174
Repurchase of Common Equity		 -118 92 -202 -44 -299 -40 - 186 -23
Issuance of Debt		 285 930 20 313 310 190 - - 170
Other Financing Activities, net		 -39 -104 99 -18 -60 -2.60 -2.40 -48 -329
Cash Interest Paid		 15 14 12 12 15 13 13 13 19
Cash Income Taxes Paid		 19 20 33 34 5.60 51 46 73 71

Annual Balance Sheets for Celestica

This table presents Celestica's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,822 2,964 3,738 3,561 3,664 4,667 5,628 5,891 5,988 7,213
Total Current Assets		 2,347 2,477 2,796 2,592 2,737 3,435 4,327 4,511 4,512 5,673
Cash & Equivalents		 557 515 422 480 464 394 375 370 423 596
Accounts Receivable		 791 1,024 1,207 1,053 1,093 1,260 1,394 1,796 2,069 2,638
Inventories, net		 891 824 1,090 992 1,092 1,697 2,350 2,104 1,761 2,188
Other Current Assets		 103 112 73 59 82 75 203 228 259 252
Plant, Property, & Equipment, net		 769 663 575 355 333 339 13 0.00 0.00 0.00
Total Noncurrent Assets		 457 461 942 614 594 893 1,301 1,380 1,476 1,540
Goodwill		 23 23 198 198 199 324 322 322 341 333
Intangible Assets		 26 22 284 251 229 382 347 318 308 266
Noncurrent Deferred & Refundable Income Taxes		 36 38 37 34 40 48 69 57 88 156
Other Noncurrent Operating Assets		 391 405 396 131 127 139 564 683 740 784
Total Liabilities & Shareholders' Equity		 2,822 2,964 3,738 3,561 3,664 4,667 5,628 5,891 5,988 7,213
Total Liabilities		 1,584 1,594 2,405 2,205 2,255 3,204 3,950 4,120 4,092 4,997
Total Current Liabilities		 1,227 1,240 1,620 1,481 1,578 2,254 3,055 3,221 3,021 3,940
Short-Term Debt		 56 38 108 - - - 52 27 27 26
Accounts Payable		 877 931 1,127 898 855 1,238 1,441 1,298 1,295 1,866
Accrued Expenses		 262 233 320 371 553 884 1,462 1,811 1,607 1,897
Current Deferred & Payable Income Tax Liabilities		 32 38 42 47 52 62 82 64 94 151
Total Noncurrent Liabilities		 1,584 1,594 785 136 150 168 895 899 1,071 1,057
Long-Term Debt		 189 167 650 - - - 734 648 770 751
Noncurrent Deferred & Payable Income Tax Liabilities		 35 28 26 28 32 60 52 42 49 41
Noncurrent Employee Benefit Liabilities		 86 98 89 107 117 108 77 84 84 90
Other Noncurrent Operating Liabilities		 1,274 1,302 21 - - - 33 125 167 176
Total Equity & Noncontrolling Interests		 3,247 3,403 1,907 1,356 1,409 1,463 1,691 1,771 1,896 0.00
Total Preferred & Common Equity		 3,247 3,403 1,907 1,356 1,409 1,463 1,691 1,771 1,896 2,216
Total Common Equity		 3,247 3,403 1,907 374 435 433 1,691 1,771 1,896 0.00

Quarterly Balance Sheets for Celestica

This table presents Celestica's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 5,835 6,241 6,607 8,260
Total Current Assets		 4,377 4,771 5,143 6,397
Cash & Equivalents		 303 314 306 378
Accounts Receivable		 2,136 2,288 2,439 3,167
Inventories, net		 1,788 1,918 2,047 2,673
Other Current Assets		 149 251 351 179
Plant, Property, & Equipment, net		 537 0.00 552 711
Total Noncurrent Assets		 922 1,470 912 1,152
Goodwill		 341 341 341 333
Intangible Assets		 298 287 275 256
Noncurrent Deferred & Refundable Income Taxes		 87 95 100 182
Other Noncurrent Operating Assets		 197 747 196 381
Total Liabilities & Shareholders' Equity		 5,835 6,241 6,607 8,260
Total Liabilities		 4,278 4,483 4,578 6,162
Total Current Liabilities		 3,054 3,321 3,502 5,081
Short-Term Debt		 27 27 27 26
Accounts Payable		 1,378 1,595 1,680 3,088
Accrued Expenses		 1,532 1,576 1,673 1,792
Current Deferred & Payable Income Tax Liabilities		 118 123 122 174
Total Noncurrent Liabilities		 1,224 1,162 1,076 1,081
Long-Term Debt		 915 849 757 747
Noncurrent Deferred & Payable Income Tax Liabilities		 49 43 45 40
Noncurrent Employee Benefit Liabilities		 85 91 94 89
Other Noncurrent Operating Liabilities		 175 180 180 205
Total Equity & Noncontrolling Interests		 0.00 0.00 0.00 0.00
Total Preferred & Common Equity		 1,557 1,758 2,029 2,098
Total Common Equity		 0.00 0.00 0.00 0.00

Annual Metrics And Ratios for Celestica

This table displays calculated financial ratios and metrics derived from Celestica's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 115,036,621.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 115,036,621.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 7.24
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 139 273 211 44 156 152 139 218 270 482 881
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 8.80% 11.05% 17.90% 29.44%
Earnings before Interest and Taxes (EBIT)		 176 287 239 24 141 151 168 291 385 584 1,036
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 244 363 315 113 276 276 294 407 516 736 1,212
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -196 680 -2,172 768 183 -192 19 297 288 753
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 469 0.00 2,216 1,603 1,572 1,903 2,102 2,076 2,269 2,397
Increase / (Decrease) in Invested Capital		 0.00 469 -469 2,216 -613 -31 331 199 -26 194 128
Book Value per Share		 $0.00 $22.90 $0.00 $13.45 $2.74 $3.37 $3.36 $13.56 $14.56 $15.94 $19.27
Tangible Book Value per Share		 $0.00 $22.56 $0.00 $10.05 ($0.56) $0.05 ($2.12) $8.20 $9.30 $10.49 $14.06
Total Capital		 0.00 3,492 0.00 2,665 1,356 1,409 1,463 2,477 2,446 2,693 2,993
Total Debt		 0.00 245 0.00 758 0.00 0.00 0.00 786 675 797 777
Total Long-Term Debt		 0.00 189 0.00 650 0.00 0.00 0.00 734 648 770 751
Net Debt		 0.00 -294 0.00 336 -480 -464 -394 412 305 373 181
Capital Expenditures (CapEx)		 -66 -65 -103 79 -36 51 50 109 122 168 201
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 618 0.00 862 631 695 788 950 947 1,094 1,164
Debt-free Net Working Capital (DFNWC)		 0.00 1,176 0.00 1,284 1,111 1,159 1,182 1,324 1,317 1,517 1,760
Net Working Capital (NWC)		 0.00 1,120 0.00 1,176 1,111 1,159 1,182 1,272 1,290 1,491 1,734
Net Nonoperating Expense (NNE)		 4.79 -3.95 0.00 20 44 30 16 38 26 54 49
Net Nonoperating Obligations (NNO)		 0.00 -2,778 0.00 309 247 163 440 412 305 373 181
Total Depreciation and Amortization (D&A)		 68 76 77 89 135 125 126 116 131 152 176
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.43 $0.00 $0.73 $0.71 $0.54 $0.00 $0.82 $1.18 $2.04 $3.62 $7.22
Adjusted Weighted Average Basic Shares Outstanding		 155.80M 0.00 143.10M 139.40M 131M 129.05M 126.70M 123.50M 118.95M 118.10M 115.30M
Adjusted Diluted Earnings per Share		 $0.42 $0.00 $0.72 $0.70 $0.53 $0.00 $0.82 $1.18 $2.03 $3.61 $7.16
Adjusted Weighted Average Diluted Shares Outstanding		 157.90M 0.00 145.20M 140.60M 131.80M 129.05M 126.70M 123.60M 118.95M 118.70M 116.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 141.81M 136.29M 128.79M 129.05M 124.71M 121.64M 118.95M 115.96M 114.97M
Normalized Net Operating Profit after Tax (NOPAT)		 139 273 211 69 156 152 139 223 280 498 906
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Celestica

This table displays calculated financial ratios and metrics derived from Celestica's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - 118,952,174.00 - - - 115,036,621.00 114,967,854.00
DEI Adjusted Shares Outstanding		 - - - 118,952,174.00 - - - 115,036,621.00 114,967,854.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - 1.28 - - - 2.33 1.85
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% - 19.91% 20.97% 27.79% - 52.80%
EBITDA Growth		 0.00% 0.00% 0.00% - 6.39% 91.11% 108.60% - 89.26%
EBIT Growth		 0.00% 0.00% 0.00% - 6.88% 110.74% 139.42% - 113.74%
NOPAT Growth		 0.00% 0.00% 0.00% - -11.05% 100.89% 181.06% - 130.82%
Net Income Growth		 0.00% 0.00% 0.00% - -6.10% 122.11% 199.22% - 146.29%
EPS Growth		 0.00% 0.00% 0.00% - -3.90% 127.50% 208.00% - 147.30%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% - 20.54% 53.01% 2.77% - 173.45%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 96.58%
Invested Capital Growth		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 13.53%
Revenue Q/Q Growth		 0.00% 8.28% 4.50% - 0.00% 9.24% 10.39% - 10.73%
EBITDA Q/Q Growth		 0.00% 6.78% 5.50% - 0.00% 91.81% 15.15% - -14.92%
EBIT Q/Q Growth		 0.00% 7.80% 5.21% - 0.00% 112.56% 19.53% - -13.25%
NOPAT Q/Q Growth		 0.00% 1.33% -10.46% - 0.00% 128.85% 25.27% - -19.25%
Net Income Q/Q Growth		 0.00% 3.49% -5.79% - 0.00% 144.78% 26.92% - -20.64%
EPS Q/Q Growth		 0.00% 3.90% -6.25% - 0.00% 145.95% 26.92% - -20.09%
Operating Cash Flow Q/Q Growth		 0.00% -7.86% 23.29% - 0.00% 16.96% -17.19% - 42.18%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% - 0.00% 0.10% -6.25% - -147.39%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% - 0.00% 5.64% 8.08% - 3.98%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 10.05% 10.61% 10.43% - 10.34% 12.82% 13.03% - 10.80%
EBITDA Margin		 7.01% 6.92% 6.98% - 6.22% 10.92% 11.40% - 7.71%
Operating Margin		 5.70% 5.56% 5.52% - 4.86% 9.42% 10.18% - 6.72%
EBIT Margin		 5.40% 5.37% 5.41% - 4.81% 9.36% 10.13% - 6.73%
Profit (Net Income) Margin		 4.16% 3.97% 3.58% - 3.25% 7.29% 8.38% - 5.25%
Tax Burden Percent		 87.26% 83.70% 72.18% - 75.81% 82.01% 86.14% - 82.83%
Interest Burden Percent		 88.26% 88.33% 91.72% - 89.25% 95.01% 96.05% - 94.12%
Effective Tax Rate		 12.74% 16.30% 27.82% - 24.19% 17.99% 13.86% - 17.17%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% - 33.87% 70.51% 78.89% - 32.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% - 32.83% 69.44% 77.92% - 32.20%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 30.33%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% - 8.31% 15.88% 17.31% - 13.17%
Return on Assets (ROA)		 0.00% 0.00% 0.00% - 5.63% 12.37% 14.32% - 10.26%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% - 27.13% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 110 111 100 162 98 223 280 279 225
NOPAT Margin		 4.97% 4.65% 3.99% - 3.69% 7.72% 8.76% - 5.57%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% - 1.04% 1.07% 0.97% - 0.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 6.02% 10.37% 25.53% 35.70% 9.33% 29.18%
Cost of Revenue to Revenue		 89.95% 89.39% 89.57% - 89.66% 87.18% 86.97% - 89.20%
SG&A Expenses to Revenue		 2.93% 3.32% 3.67% - 4.25% 1.34% 1.20% - 2.90%
R&D to Revenue		 0.75% 0.81% 0.75% - 0.66% 1.18% 1.14% - 1.02%
Operating Expenses to Revenue		 4.36% 5.05% 4.91% - 5.48% 3.40% 2.85% - 4.08%
Earnings before Interest and Taxes (EBIT)		 119 129 135 201 127 271 324 314 272
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 155 165 175 241 165 316 364 367 312
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 - 0.91 1.70 2.51 - 2.35
Price to Earnings (P/E)		 0.00 0.00 0.00 - 21.64 33.34 39.54 - 33.78
Dividend Yield		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% - 4.62% 3.00% 2.53% - 2.96%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 - 4.45 7.98 11.50 - 13.15
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 - 0.97 1.75 2.55 - 2.38
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 - 13.10 20.64 26.53 - 24.13
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 - 16.50 25.19 31.21 - 27.76
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 - 20.78 31.72 37.72 - 32.51
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 - 19.71 33.73 52.18 - 37.02
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 46.10
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Financial Leverage		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Leverage Ratio		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Compound Leverage Factor		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Debt to Total Capital		 0.00% 0.00% 0.00% - 100.00% 100.00% 100.00% - 100.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% - 2.84% 3.04% 3.49% - 3.35%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% - 97.16% 96.96% 96.51% - 96.65%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Debt to EBITDA		 0.00 0.00 0.00 - 1.26 0.98 0.72 - 0.57
Net Debt to EBITDA		 0.00 0.00 0.00 - 0.86 0.63 0.44 - 0.29
Long-Term Debt to EBITDA		 0.00 0.00 0.00 - 1.23 0.95 0.70 - 0.55
Debt to NOPAT		 0.00 0.00 0.00 - 2.00 1.50 1.03 - 0.77
Net Debt to NOPAT		 0.00 0.00 0.00 - 1.36 0.96 0.63 - 0.39
Long-Term Debt to NOPAT		 0.00 0.00 0.00 - 1.94 1.45 0.99 - 0.74
Altman Z-Score		 0.00 0.00 0.00 - 3.35 4.52 5.88 - 5.12
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 - 1.43 1.44 1.47 - 1.26
Quick Ratio		 0.00 0.00 0.00 - 0.80 0.78 0.78 - 0.70
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -2,098 -2,096 -2,227 151 -72
Operating Cash Flow to CapEx		 267.57% 269.92% 266.96% - 355.04% 468.92% 338.34% - 163.14%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 - -153.13 -155.25 -173.97 - -4.48
Operating Cash Flow to Interest Expense		 7.72 6.64 10.96 - 9.51 11.29 9.86 - 22.27
Operating Cash Flow Less CapEx to Interest Expense		 4.84 4.18 6.86 - 6.83 8.88 6.95 - 8.62
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 - 1.73 1.70 1.71 - 1.96
Accounts Receivable Turnover		 0.00 0.00 0.00 - 4.72 4.63 4.63 - 5.20
Inventory Turnover		 0.00 0.00 0.00 - 5.03 4.89 4.85 - 5.44
Fixed Asset Turnover		 0.00 0.00 0.00 - 18.80 0.00 20.44 - 22.10
Accounts Payable Turnover		 0.00 0.00 0.00 - 6.53 5.88 5.91 - 5.43
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 - 77.30 78.87 78.92 - 70.19
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 - 72.52 74.60 75.28 - 67.11
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 - 55.88 62.04 61.79 - 67.18
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 - 93.95 91.43 92.41 - 70.12
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 2,269 2,196 2,319 2,507 2,397 2,493
Invested Capital Turnover		 0.00 0.00 0.00 - 9.19 9.13 9.00 - 5.88
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 2,196 2,319 2,507 128 297
Enterprise Value (EV)		 0.00 0.00 0.00 - 9,777 18,513 28,820 - 32,779
Market Capitalization		 5,346 6,820 6,081 - 9,139 17,951 28,342 - 32,384
Book Value per Share		 $0.00 $0.00 $0.00 $15.94 $0.00 $0.00 $0.00 $19.27 $0.00
Tangible Book Value per Share		 $0.00 $0.00 $0.00 $10.49 ($5.50) ($5.46) ($5.36) $14.06 ($5.12)
Total Capital		 0.00 0.00 0.00 2,693 942 875 784 2,993 772
Total Debt		 0.00 0.00 0.00 797 942 875 784 777 772
Total Long-Term Debt		 0.00 0.00 0.00 770 915 849 757 751 747
Net Debt		 0.00 0.00 0.00 373 639 561 478 181 394
Capital Expenditures (CapEx)		 40 37 46 48 37 33 37 95 218
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 1,094 1,046 1,163 1,362 1,164 964
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 1,517 1,349 1,477 1,668 1,760 1,342
Net Working Capital (NWC)		 0.00 0.00 0.00 1,491 1,322 1,450 1,641 1,734 1,316
Net Nonoperating Expense (NNE)		 18 16 10 10 11 12 12 12 13
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 373 2,196 2,319 2,507 181 2,493
Total Depreciation and Amortization (D&A)		 36 37 39 40 37 45 40 53 40
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% - 10.37% 10.99% 12.07% - 6.99%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% - 13.38% 13.95% 14.78% - 9.73%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% - 13.11% 13.70% 14.54% - 9.55%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $1.29 $0.74 $1.83 $2.33 $2.32 $1.85
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 118.10M 115.90M 115.10M 115M 115.30M 114.90M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $1.29 $0.74 $1.82 $2.31 $2.29 $1.83
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 118.70M 116.90M 115.90M 115.90M 116.20M 115.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 115.96M 114.99M 115.03M 115.04M 114.97M 114.97M
Normalized Net Operating Profit after Tax (NOPAT)		 114 121 100 164 101 235 284 285 222
Normalized NOPAT Margin		 5.16% 5.05% 4.01% - 3.80% 8.13% 8.90% - 5.48%
Pre Tax Income Margin		 4.76% 4.75% 4.96% - 4.29% 8.89% 9.73% - 6.33%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 8.51 8.57 12.07 - 9.30 20.06 25.29 - 17.02
NOPAT to Interest Expense		 7.84 7.42 8.89 - 7.13 16.55 21.87 - 14.09
EBIT Less CapEx to Interest Expense		 5.63 6.11 7.96 - 6.62 17.65 22.38 - 3.37
NOPAT Less CapEx to Interest Expense		 4.96 4.96 4.79 - 4.45 14.15 18.96 - 0.44
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% - 107.20% 108.54% 53.41% - -12.86%

Financials Breakdown Chart

Key Financial Trends

Celestica Inc. (CLS) shows improving profitability and cash generation in 2025 based on the quarterly data provided, with rising revenue, steadier gross margins, stronger operating cash flow, and some balance-sheet deleveraging. Below are the key takeaways, focusing on trends over the last four years of quarterly results.

  • Revenue growth in 2025: Q4 2025 operating revenue of 3,654.9 million, up from Q4 2024's 2,545.7 million (roughly +43%).
  • Net income growth: Net income from continuing operations in Q4 2025 was 267.5 million, up from 151.7 million in Q4 2024 (and Q3 2025 was 267.8 million), signaling stronger quarterly profitability.
  • Earnings per share gains: Q4 2025 basic EPS of 2.32 and diluted EPS of 2.29, versus Q4 2024 basic/diluted EPS of 1.29, reflecting improved per-share profitability.
  • Operating cash flow strength: Net cash from continuing operating activities rose to 250.6 million in Q4 2025 from 143.4 million in Q4 2024, indicating better cash generation from core operations.
  • Free cash flow positive in Q4 2025: Approximately 155.9 million (250.6 million - 94.7 million capex), illustrating cash generation after maintaining essential capital investments.
  • Deleveraging progress: Long-term debt declined to 756.7 million by Q3 2025 from 915.0 million in Q1 2025, signaling reduced leverage.
  • Liquidity and short-term balance: Total current assets around 5.14B and total current liabilities around 3.50B in Q3 2025 yield a current ratio near 1.5x, suggesting solid near-term liquidity.
  • Margin dynamics: Gross margin hovered in the low-teens in late 2025 (Q3 2025 gross margin about 13.0%; Q4 2025 about 11.8%), indicating improving profitability with room for continued improvement.
  • Capex variability: Quarterly capital expenditures ranged roughly from 32.5M to 94.7M in 2025, indicating ongoing investment without a single, clear quarterly trend.
  • Investing cash outflow remains meaningful: Net cash from investing activities was negative in each 2025 quarter (e.g., Q4 -94.7M; Q3 -37.3M; Q2 -32.5M; Q1 -36.7M), reflecting ongoing capital expenditure rather than cash returns.

Bottom line: CLS shows improving top-line growth, better profitability per share, stronger operating cash flow, and some deleveraging in 2025. However, cash outflows from investing activities persist, and financing cash flows have been mixed, highlighting ongoing capital investment needs and periodic funding considerations.

05/19/26 03:53 AM ETAI Generated. May Contain Errors.

Celestica Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Celestica's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Celestica's net income appears to be on an upward trend, with a most recent value of $832.50 million in 2025, rising from $133.80 million in 2015. The previous period was $428 million in 2024. Check out Celestica's forecast to explore projected trends and price targets.

Celestica's total operating income in 2025 was $1.04 billion, based on the following breakdown:
  • Total Gross Profit: $1.49 billion
  • Total Operating Expenses: $453.40 million

Over the last 10 years, Celestica's total revenue changed from $5.67 billion in 2015 to $12.39 billion in 2025, a change of 118.5%.

Celestica's total liabilities were at $5.00 billion at the end of 2025, a 22.1% increase from 2024, and a 215.6% increase since 2016.

In the past 9 years, Celestica's cash and equivalents has ranged from $370.40 million in 2023 to $595.60 million in 2025, and is currently $595.60 million as of their latest financial filing in 2025.

Over the last 10 years, Celestica's book value per share changed from 0.00 in 2015 to 19.27 in 2025, a change of 1,926.6%.


Related Companies

Financial statements for NYSE:CLS last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel